HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory bioma...
HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1)
About this item
Full title
Author / Creator
Ri, Masaki , Iida, Shinsuke , Maruyama, Dai , Sakabe, Aya , Kamei, Ryo , Nakashima, Takuto , Tohkin, Masahiro , Osaga, Satoshi , Tobinai, Kensei , Fukuhara, Noriko , Miyazaki, Kana , Tsukamoto, Norifumi , Tsujimura, Hideki , Yoshimitsu, Makoto , Miyamoto, Kenichi , Tsukasaki, Kunihiro and Nagai, Hirokazu
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Bortezomib (Btz) shows robust efficacy in patients with multiple myeloma (MM); however, some patients experience suboptimal responses and show specific toxicities. Therefore, we attempted to identify specific HLA alleles associated with Btz‐related toxicities and response to treatment. Eighty‐two transplant‐ineligible patients with newly diagnosed...
Alternative Titles
Full title
HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8645746
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8645746
Other Identifiers
ISSN
1347-9032,1349-7006
E-ISSN
1349-7006
DOI
10.1111/cas.15158
